GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » Net Margin %

Jerusalem Pharmaceutical Co (XPAE:JPH) Net Margin % : 18.76% (As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Jerusalem Pharmaceutical Co's Net Income for the three months ended in Dec. 2024 was $2.51 Mil. Jerusalem Pharmaceutical Co's Revenue for the three months ended in Dec. 2024 was $13.35 Mil. Therefore, Jerusalem Pharmaceutical Co's net margin for the quarter that ended in Dec. 2024 was 18.76%.

The historical rank and industry rank for Jerusalem Pharmaceutical Co's Net Margin % or its related term are showing as below:

XPAE:JPH' s Net Margin % Range Over the Past 10 Years
Min: 8.99   Med: 14.91   Max: 20.58
Current: 12.65


XPAE:JPH's Net Margin % is ranked better than
74.52% of 981 companies
in the Drug Manufacturers industry
Industry Median: 4.56 vs XPAE:JPH: 12.65

Jerusalem Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Jerusalem Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jerusalem Pharmaceutical Co Net Margin % Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.23 14.27 15.55 17.54 12.65

Jerusalem Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.42 3.46 10.98 13.19 18.76

Competitive Comparison of Jerusalem Pharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Net Margin % falls into.


;
;

Jerusalem Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Jerusalem Pharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=5.04/39.852
=12.65 %

Jerusalem Pharmaceutical Co's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=2.505/13.35
=18.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jerusalem Pharmaceutical Co  (XPAE:JPH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Jerusalem Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines